Cargando…
c-Abl and Arg are activated in human primary melanomas, promote melanoma cell invasion via distinct pathways, and drive metastatic progression
Despite 35 years of clinical trials, there is little improvement in one-year survival rates for patients with metastatic melanoma, and the disease is essentially untreatable if not cured surgically. The paucity of chemotherapeutic agents that are effective for treating metastatic melanoma indicates...
Autores principales: | Ganguly, Sourik S., Fiore, Leann S., Sims, Jonathan T., Friend, J. Woodrow, Srinivasan, Divyamani, Thacker, Matthew A., Cibull, Michael L., Wang, Chi, Novak, Marian, Kaetzel, David M., Plattner, Rina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235241/ https://www.ncbi.nlm.nih.gov/pubmed/21892207 http://dx.doi.org/10.1038/onc.2011.361 |
Ejemplares similares
-
c-Abl and Arg induce cathepsin-mediated lysosomal degradation of the NM23-H1 metastasis suppressor in invasive cancer
por: Fiore, Leann S., et al.
Publicado: (2013) -
Imatinib Reverses Doxorubicin Resistance by Affecting Activation of STAT3-Dependent NF-κB and HSP27/p38/AKT Pathways and by Inhibiting ABCB1
por: Sims, Jonathan T., et al.
Publicado: (2013) -
Abl Kinase Regulation by BRAF/ERK and Cooperation with Akt in Melanoma
por: Jain, Aditi, et al.
Publicado: (2017) -
ABL1/2 and DDR1 Drive MEKi Resistance in NRAS-Mutant Melanomas by Stabilizing RAF/MYC/ETS1 and Promoting RAF Homodimerization
por: Lyon, Anastasia, et al.
Publicado: (2023) -
NM23 deficiency promotes metastasis in a UV radiation-induced mouse model of human melanoma
por: Jarrett, Stuart G., et al.
Publicado: (2012)